mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.078 |
0.1 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.076 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.1 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |